Consensus cbdMD, Inc.

Equities

YCBD

US12482W4087

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:00 2025-06-20 pm EDT			5-day change	1st Jan Change
0.8200 ^USD	-2.15%		-4.54%	-72.67%

May. 15	CbdMD, Inc., Q2 2025 Earnings Call, May 15, 2025
May. 15	CbdMD, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2025	CI

Evolution of the Average Target: cbdMD, Inc.

Evolution of the Target Price: cbdMD, Inc.

Changes in Analyst Recommendations: cbdMD, Inc.

4b4044e961f9a92f0de0e3cd57.2a7eoEtfoNiWzy5DkLXe-jMDF5PRcLDYc4Qr8q_PqIg.4MnuyC4P1JbGnRwHqOSsrEtQX8OZQP6MIehkn5ya79iM56fiewqXkeaGHg~8ced607cd7cc07a131df5aa35e05e5d7

Analysts' recommendations: cbdMD, Inc.

Maxim Starts Coverage on cbdMD with Buy Rating, $3 Price Target	23-10-05	MT
CBDMD : Cantor Fitzgerald Adjusts Price Target for cbdMD to $3.25 from $4.10, Maintains Neutral Rating	21-06-18	MT

More recommendations